TENEX nonclinical toxicology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Guanfacine}} {{CMG}}; {{AE}} {{SS}} ==Nonclinical Toxicology== Carcinogenesis, Mutagenesis, Impairment of Fertility No carcinogenic effect was observed in studi...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Guanfacine#Nonclinical Toxicology]]
{{Guanfacine}}
{{CMG}}; {{AE}} {{SS}}
 
==Nonclinical Toxicology==
 
Carcinogenesis, Mutagenesis, Impairment of Fertility
 
No carcinogenic effect was observed in studies of 78 weeks in mice at doses more than 150 times the maximum recommended human dose and 102 weeks in rats at doses more than 100 times the maximum recommended human dose. In a variety of test models, guanfacine was not mutagenic.
 
No adverse effects were observed in fertility studies in male and female rats.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TENEX (GUANFACINE HYDROCHLORIDE) TABLET [PROMIUS PHARMA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=886e050c-dd22-4f35-ac3b-243f091125c3#nlm34067-9 | publisher =  | date =  | accessdate = 25 February 2014 }}</ref>
 
==References==
{{reflist|2}}
 
{{Antihypertensives and diuretics}}
{{Antihyperkinetics}}
{{Adrenergics}}
 
[[Category:Antihypertensive agents]]
[[Category:Guanidines]]
[[Category:Alpha-adrenergic agonists]]
[[Category:Acetamides]]
[[Category:Organochlorides]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 03:37, 22 July 2014